Providing innovative solutions for over 30 years.

Innovations with Ed Begley, Jr. featuring Molecular Devices

Innovations TV tours our corporate offices and laboratories in San Jose, California to demonstrate how new technologies enable great insights. Greg Milosevich, President of Molecular Devices provides an overview of our sophisticated portfolio and its impact on the development of novel therapeutics. Fabian Zanella Ph.D., Director of R&D for StemoniX Inc., a leading provider of ready-to-use preclinical plates of biologically-relevant human micro-organs, speaks to the latest advancements in stem cell research. Zanella also explains the importance of sophisticated instrumentation in the fast-paced environment of cell biology.

First microplate reader in space

Molecular Devices SpectraMax M5e reader, chosen for its durability, became the first microplate reader in space in May 2011. NanoRacks, a leading provider of commercial pathway solutions aboard the International Space Station, added the reader to their line of commercial research hardware, providing researchers the ability to conduct microplate reader experiments in microgravity for the first time.

They reconfigured the reader to operate comfortably in the zero-gravity environment of the space station. Upgrades included temperature control and the ability to configure every aspect of the researcher’s experiment from an Earth-based workstation using SoftMax® Pro, the leading data acquisition and analysis software. NanoRacks re-launched the reconfigured SpectraMax M5e reader back to the International Space Station on the SpaceX Commercial Resupply Mission-9 on July 18, 2016.

Our Patents

At Molecular Devices, we provide one of the widest ranges of bioanalytical systems for life science and drug discovery research available from a single supplier. Our systems are built on proprietary technology platforms that deliver high performance, flexibility, and reliability. Some of our key patented technologies can be viewed here. For more information about any of these technologies, please contact us directly.

R&D Service